Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market 2020 by Company, Regions, Type and Application, Forecast to 2025

  • receipt Report ID : 85008
  • calendar_today Published On: Aug, 2020
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

Market Overview

The Contract Research Organization (CRO) and CDMO for Pharmaceutical market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global Contract Research Organization (CRO) and CDMO for Pharmaceutical sales will be xx in 2020 from Contract Research Organization (CRO) and CDMO for Pharmaceutical million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Contract Research Organization (CRO) and CDMO for Pharmaceutical market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the Contract Research Organization (CRO) and CDMO for Pharmaceutical industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Contract Research Organization (CRO) and CDMO for Pharmaceutical and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation

Contract Research Organization (CRO) and CDMO for Pharmaceutical market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Contract Research Organization (CRO) and CDMO for Pharmaceutical market has been segmented into:

Development

API production

Formulation

By Application, Contract Research Organization (CRO) and CDMO for Pharmaceutical has been segmented into:

Pharmaceutical

Biopharmaceutical

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Contract Research Organization (CRO) and CDMO for Pharmaceutical market presented in the report. This section sheds light on the sales growth of different regional and country-level Contract Research Organization (CRO) and CDMO for Pharmaceutical markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Contract Research Organization (CRO) and CDMO for Pharmaceutical market.

The report offers in-depth assessment of the growth and other aspects of the Contract Research Organization (CRO) and CDMO for Pharmaceutical market in important countries (regions), including:

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Share Analysis

Contract Research Organization (CRO) and CDMO for Pharmaceutical competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Contract Research Organization (CRO) and CDMO for Pharmaceutical sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Contract Research Organization (CRO) and CDMO for Pharmaceutical sales, revenue and market share for each player covered in this report.

The major players covered in Contract Research Organization (CRO) and CDMO for Pharmaceutical are:

Recipharm

Strides Shasun

Aenova

AMRI3

WuXi PharmaTech

Patheon

Siegfried

Amatsigroup

Catalent

Piramal

Among other players domestic and global, Contract Research Organization (CRO) and CDMO for Pharmaceutical market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Overview

1.1 Product Overview and Scope of Contract Research Organization (CRO) and CDMO for Pharmaceutical

1.2 Classification of Contract Research Organization (CRO) and CDMO for Pharmaceutical by Type

1.2.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type: 2015 VS 2019 VS 2025

1.2.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Type in 2019

1.2.3 Development

1.2.4 API production

1.2.5 Formulation

1.3 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market by Application

1.3.1 Overview: Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application: 2015 VS 2019 VS 2025

1.3.2 Pharmaceutical

1.3.3 Biopharmaceutical

1.4 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market by Regions

1.4.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Regions: 2015 VS 2019 VS 2025

1.4.2 Global Market Size of Contract Research Organization (CRO) and CDMO for Pharmaceutical (2015-2025)

1.4.3 North America (USA, Canada and Mexico) Contract Research Organization (CRO) and CDMO for Pharmaceutical Status and Prospect (2015-2025)

1.4.4 Europe (Germany, France, UK, Russia and Italy) Contract Research Organization (CRO) and CDMO for Pharmaceutical Status and Prospect (2015-2025)

1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Contract Research Organization (CRO) and CDMO for Pharmaceutical Status and Prospect (2015-2025)

1.4.6 South America (Brazil, Argentina, Colombia) Contract Research Organization (CRO) and CDMO for Pharmaceutical Status and Prospect (2015-2025)

1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Contract Research Organization (CRO) and CDMO for Pharmaceutical Status and Prospect (2015-2025)

1.5 COVID-19 Outbreak: Contract Research Organization (CRO) and CDMO for Pharmaceutical Industry Impact

1.5.1 COVID-19 Potential Implications for the Contract Research Organization (CRO) and CDMO for Pharmaceutical

1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Contract Research Organization (CRO) and CDMO for Pharmaceutical

1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April

1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4

1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2

1.5.2 Opportunity Analysis in Covid-19 Crisis

1.5.3 Market Risk and Restraints

1.5.4 Market Driving Force

2 Company Profiles

2.1 Recipharm

2.1.1 Recipharm Details

2.1.2 Recipharm Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 Recipharm SWOT Analysis

2.1.4 Recipharm Product and Services

2.1.5 Recipharm Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2019)

2.2 Strides Shasun

2.2.1 Strides Shasun Details

2.2.2 Strides Shasun Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 Strides Shasun SWOT Analysis

2.2.4 Strides Shasun Product and Services

2.2.5 Strides Shasun Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2019)

2.3 Aenova

2.3.1 Aenova Details

2.3.2 Aenova Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 Aenova SWOT Analysis

2.3.4 Aenova Product and Services

2.3.5 Aenova Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2019)

2.4 AMRI3

2.4.1 AMRI3 Details

2.4.2 AMRI3 Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 AMRI3 SWOT Analysis

2.4.4 AMRI3 Product and Services

2.4.5 AMRI3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2019)

2.5 WuXi PharmaTech

2.5.1 WuXi PharmaTech Details

2.5.2 WuXi PharmaTech Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 WuXi PharmaTech SWOT Analysis

2.5.4 WuXi PharmaTech Product and Services

2.5.5 WuXi PharmaTech Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2019)

2.6 Patheon

2.6.1 Patheon Details

2.6.2 Patheon Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 Patheon Product and Services

2.6.4 Patheon Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2019)

2.7 Siegfried

2.7.1 Siegfried Details

2.7.2 Siegfried Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 Siegfried Product and Services

2.7.4 Siegfried Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2019)

2.8 Amatsigroup

2.8.1 Amatsigroup Details

2.8.2 Amatsigroup Major Business and Total Revenue (Financial Highlights) Analysis

2.8.3 Amatsigroup Product and Services

2.8.4 Amatsigroup Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2019)

2.9 Catalent

2.9.1 Catalent Details

2.9.2 Catalent Major Business and Total Revenue (Financial Highlights) Analysis

2.9.3 Catalent Product and Services

2.9.4 Catalent Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2019)

2.10 Piramal

2.10.1 Piramal Details

2.10.2 Piramal Major Business and Total Revenue (Financial Highlights) Analysis

2.10.3 Piramal Product and Services

2.10.4 Piramal Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

3.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Share by Players (2015-2020)

3.2 Market Concentration Rate

3.2.1 Top 5 Contract Research Organization (CRO) and CDMO for Pharmaceutical Players Market Share

3.2.2 Top 10 Contract Research Organization (CRO) and CDMO for Pharmaceutical Players Market Share

3.3 Market Competition Trend

4 Market Size by Regions

4.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Market Share by Regions

4.2 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

4.3 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

4.4 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

4.5 South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

4.6 Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

5 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Countries

5.1 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Countries (2015-2020)

5.2 USA Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

5.3 Canada Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

5.4 Mexico Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

6 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Countries

6.1 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Countries (2015-2020)

6.2 Germany Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

6.3 UK Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

6.4 France Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

6.5 Russia Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

6.6 Italy Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

7 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Countries

7.1 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Countries (2015-2020)

7.2 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

7.3 Japan Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

7.4 Korea Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

7.5 India Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

7.6 Southeast Asia Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

8 South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Countries

8.1 South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Countries (2015-2020)

8.2 Brazil Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

8.3 Argentina Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

9 Middle East & Africa Revenue Contract Research Organization (CRO) and CDMO for Pharmaceutical by Countries

9.1 Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Countries (2015-2020)

9.2 Saudi Arabia Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

9.3 UAE Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

9.4 Egypt Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

9.5 South Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

10 Market Size Segment by Type

10.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Market Share by Type (2015-2020)

10.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Forecast by Type (2019-2024)

10.3 Development Revenue Growth Rate (2015-2025)

10.4 API production Revenue Growth Rate (2015-2025)

10.5 Formulation Revenue Growth Rate (2015-2025)

11 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Segment by Application

11.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Application (2015-2020)

11.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Forecast by Application (2019-2024)

11.3 Pharmaceutical Revenue Growth (2015-2020)

11.4 Biopharmaceutical Revenue Growth (2015-2020)

12 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size Forecast (2021-2025)

12.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size Forecast (2021-2025)

12.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Forecast by Regions (2021-2025)

12.3 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Forecast (2021-2025)

12.4 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Forecast (2021-2025)

12.5 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Forecast (2021-2025)

12.6 South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Forecast (2021-2025)

12.7 Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Forecast (2021-2025)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

14.3 Disclaimer

14.4 About US

List of Tables

Table 1. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million) by Type: 2015 VS 2019 VS 2025

Table 2. Breakdown of Contract Research Organization (CRO) and CDMO for Pharmaceutical by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million) by Application: 2015 VS 2019 VS 2025

Table 4. Global Market Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (Million USD) Comparison by Regions 2015-2025

Table 5. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Growth Estimation in Various Scenarios in 2020

Table 6. Recipharm Corporate Information, Location and Competitors

Table 7. Recipharm Contract Research Organization (CRO) and CDMO for Pharmaceutical Major Business

Table 8. Recipharm Contract Research Organization (CRO) and CDMO for Pharmaceutical Total Revenue (USD Million) (2017-2018)

Table 9. Recipharm SWOT Analysis

Table 10. Recipharm Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions

Table 11. Recipharm Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 12. Strides Shasun Corporate Information, Location and Competitors

Table 13. Strides Shasun Contract Research Organization (CRO) and CDMO for Pharmaceutical Major Business

Table 14. Strides Shasun Contract Research Organization (CRO) and CDMO for Pharmaceutical Total Revenue (USD Million) (2018-2019)

Table 15. Strides Shasun SWOT Analysis

Table 16. Strides Shasun Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions

Table 17. Strides Shasun Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 18. Aenova Corporate Information, Location and Competitors

Table 19. Aenova Contract Research Organization (CRO) and CDMO for Pharmaceutical Major Business

Table 20. Aenova Contract Research Organization (CRO) and CDMO for Pharmaceutical Total Revenue (USD Million) (2017-2018)

Table 21. Aenova SWOT Analysis

Table 22. Aenova Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions

Table 23. Aenova Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 24. AMRI3 Corporate Information, Location and Competitors

Table 25. AMRI3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Major Business

Table 26. AMRI3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Total Revenue (USD Million) (2017-2018)

Table 27. AMRI3 SWOT Analysis

Table 28. AMRI3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions

Table 29. AMRI3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 30. WuXi PharmaTech Corporate Information, Location and Competitors

Table 31. WuXi PharmaTech Contract Research Organization (CRO) and CDMO for Pharmaceutical Major Business

Table 32. WuXi PharmaTech Contract Research Organization (CRO) and CDMO for Pharmaceutical Total Revenue (USD Million) (2017-2018)

Table 33. WuXi PharmaTech SWOT Analysis

Table 34. WuXi PharmaTech Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions

Table 35. WuXi PharmaTech Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 36. Patheon Corporate Information, Location and Competitors

Table 37. Patheon Contract Research Organization (CRO) and CDMO for Pharmaceutical Major Business

Table 38. Patheon Contract Research Organization (CRO) and CDMO for Pharmaceutical Total Revenue (USD Million) (2017-2018)

Table 39. Patheon SWOT Analysis

Table 40. Patheon Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions

Table 41. Patheon Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 42. Siegfried Corporate Information, Location and Competitors

Table 43. Siegfried Contract Research Organization (CRO) and CDMO for Pharmaceutical Major Business

Table 44. Siegfried Contract Research Organization (CRO) and CDMO for Pharmaceutical Total Revenue (USD Million) (2017-2018)

Table 45. Siegfried SWOT Analysis

Table 46. Siegfried Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions

Table 47. Siegfried Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 48. Amatsigroup Corporate Information, Location and Competitors

Table 49. Amatsigroup Contract Research Organization (CRO) and CDMO for Pharmaceutical Major Business

Table 50. Amatsigroup Contract Research Organization (CRO) and CDMO for Pharmaceutical Total Revenue (USD Million) (2017-2018)

Table 51. Amatsigroup SWOT Analysis

Table 52. Amatsigroup Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions

Table 53. Amatsigroup Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 54. Catalent Corporate Information, Location and Competitors

Table 55. Catalent Contract Research Organization (CRO) and CDMO for Pharmaceutical Major Business

Table 56. Catalent Contract Research Organization (CRO) and CDMO for Pharmaceutical Total Revenue (USD Million) (2017-2018)

Table 57. Catalent SWOT Analysis

Table 58. Catalent Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions

Table 59. Catalent Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 60. Piramal Corporate Information, Location and Competitors

Table 61. Piramal Contract Research Organization (CRO) and CDMO for Pharmaceutical Major Business

Table 62. Piramal Contract Research Organization (CRO) and CDMO for Pharmaceutical Total Revenue (USD Million) (2017-2018)

Table 63. Piramal SWOT Analysis

Table 64. Piramal Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions

Table 65. Piramal Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 66. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (Million USD) by Players (2015-2020)

Table 67. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Share by Players (2015-2020)

Table 68. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (Million USD) by Regions (2015-2020)

Table 69. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Regions (2015-2020)

Table 70. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Countries (2015-2020)

Table 71. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Countries (2015-2020)

Table 72. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (Million USD) by Countries (2015-2020)

Table 73. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (Million USD) by Countries (2015-2020)

Table 74. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Countries (2015-2020)

Table 75. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Countries (2015-2020)

Table 76. Middle East and Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (Million USD) by Countries (2015-2020)

Table 77. Middle East and Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Countries (2015-2020)

Table 78. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (Million USD) by Type (2015-2020)

Table 79. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Share by Type (2015-2020)

Table 80. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Forecast by Type (2021-2025)

Table 81. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2015-2020)

Table 82. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Share by Application (2015-2020)

Table 83. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Forecast by Application (2021-2025)

Table 84. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (Million USD) Forecast by Regions (2021-2025)

List of Figures

Figure 1. Contract Research Organization (CRO) and CDMO for Pharmaceutical Picture

Figure 2. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Type in 2019

Figure 3. Development Picture

Figure 4. API production Picture

Figure 5. Formulation Picture

Figure 6. Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Application in 2019

Figure 7. Pharmaceutical Picture

Figure 8. Biopharmaceutical Picture

Figure 9. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million) and Growth Rate (2015-2025)

Figure 10. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (Million USD) and Growth Rate (2015-2025)

Figure 11. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (Million USD) and Growth Rate (2015-2025)

Figure 12. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (Million USD) and Growth Rate (2015-2025)

Figure 13. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (Million USD) and Growth Rate (2015-2025)

Figure 14. Middle East and Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (Million USD) and Growth Rate (2015-2025)

Figure 15. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (Million USD) and Growth Rate (2015-2025)

Figure 16. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Share by Players in 2019

Figure 17. Global Top 5 Players Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share in 2019

Figure 18. Global Top 10 Players Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share in 2019

Figure 19. Key Players Market Share Trend

Figure 20. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (Million USD) and Growth Rate (%) (2015-2020)

Figure 21. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Regions (2015-2020)

Figure 22. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Regions in 2018

Figure 23. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

Figure 24. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

Figure 25. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

Figure 26. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

Figure 27. Middle East and Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

Figure 28. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Countries (2015-2020)

Figure 29. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Countries in 2019

Figure 30. USA Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

Figure 31. Canada Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

Figure 32. Mexico Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

Figure 33. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Countries (2015-2020)

Figure 34. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Countries in 2019

Figure 35. Germany Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

Figure 36. UK Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

Figure 37. France Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

Figure 38. Russia Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

Figure 39. Italy Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

Figure 40. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Countries (2015-2020)

Figure 41. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Countries in 2019

Figure 42. China Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

Figure 43. Japan Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

Figure 44. Korea Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

Figure 45. India Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

Figure 46. Southeast Asia Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

Figure 47. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Countries (2015-2020)

Figure 48. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Countries in 2019

Figure 49. Brazil Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

Figure 50. Argentina Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

Figure 51. Middle East and Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Countries (2015-2020)

Figure 52. Middle East and Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Countries in 2019

Figure 53. Saudi Arabia Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

Figure 54. UAE Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

Figure 55. Egypt Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

Figure 56. South Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2015-2020)

Figure 57. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Share by Type (2015-2020)

Figure 58. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Share by Type in 2019

Figure 59. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Share Forecast by Type (2021-2025)

Figure 60. Global Development Revenue Growth Rate (2015-2020)

Figure 61. Global API production Revenue Growth Rate (2015-2020)

Figure 62. Global Formulation Revenue Growth Rate (2015-2020)

Figure 63. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Share by Application (2015-2020)

Figure 64. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Share by Application in 2019

Figure 65. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Share Forecast by Application (2021-2025)

Figure 66. Global Pharmaceutical Revenue Growth Rate (2015-2020)

Figure 67. Global Biopharmaceutical Revenue Growth Rate (2015-2020)

Figure 68. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (Million USD) and Growth Rate Forecast (2021-2025)

Figure 69. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (Million USD) Forecast by Regions (2021-2025)

Figure 70. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share Forecast by Regions (2021-2025)

Figure 71. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Forecast (2021-2025)

Figure 72. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Forecast (2021-2025)

Figure 73. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Forecast (2021-2025)

Figure 74. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Forecast (2021-2025)

Figure 75. Middle East and Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Forecast (2021-2025)

Figure 76. Sales Channel: Direct Channel vs Indirect Channel